Shares of Medicure Inc. (CVE:MPH – Get Free Report) hit a new 52-week low during trading on Tuesday . The company traded as low as C$0.88 and last traded at C$0.88, with a volume of 3500 shares traded. The stock had previously closed at C$0.91.
Medicure Stock Down 3.3 %
The stock has a market cap of C$9.19 million, a PE ratio of -3.52 and a beta of 0.90. The company has a quick ratio of 1.29, a current ratio of 1.87 and a debt-to-equity ratio of 2.06. The firm has a fifty day moving average of C$0.97 and a 200 day moving average of C$1.04.
Medicure (CVE:MPH – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported C($0.12) earnings per share for the quarter. Medicure had a negative return on equity of 12.90% and a negative net margin of 12.56%. The company had revenue of C$5.17 million for the quarter. On average, equities research analysts anticipate that Medicure Inc. will post 0.0652819 EPS for the current fiscal year.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- What is Forex and How Does it Work?
- A $1.75 Billion Gamble: Can Lucid Ignite Growth?
- What Are Dividend Contenders? Investing in Dividend Contenders
- The Rally in Lockheed Martin and RTX Can Continue: Here’s Why
- What is the Shanghai Stock Exchange Composite Index?
- 3 Undervalued Technology Stocks With Big Rebound Potential
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
